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Text miningPreparing a systematic review can take hundreds of hours to complete, but the process of reconciling dif-
ferent results from multiple studies is the bedrock of evidence-based medicine. We introduce a two-step
approach to automatically extract three facets – two entities (the agent and object) and the way in which
the entities are compared (the endpoint) – from direct comparative sentences in full-text articles. The
system does not require a user to predeﬁne entities in advance and thus can be used in domains where
entity recognition is difﬁcult or unavailable. As with a systematic review, the tabular summary produced
using the automatically extracted facets shows how experimental results differ between studies.
Experiments were conducted using a collection of more than 2 million sentences from three journals
Diabetes, Carcinogenesis and Endocrinology and two machine learning algorithms, support vector machi-
nes (SVM) and a general linear model (GLM). F1 and accuracy measures for the SVM and GLM differed
by only 0.01 across all three comparison facets in a randomly selected set of test sentences. The system
achieved the best performance of 92% for objects, whereas the accuracy for both agent and endpoints was
73%. F1 scores were higher for objects (0.77) than for endpoints (0.51) or agents (0.47). A situated eval-
uation of Metformin, a drug to treat diabetes, showed system accuracy of 95%, 83% and 79% for the object,
endpoint and agent respectively. The situated evaluation had higher F1 scores of 0.88, 0.64 and 0.62 for
object, endpoint, and agent respectively. On average, only 5.31% of the sentences in a full-text article are
direct comparisons, but the tabular summaries suggest that these sentences provide a rich source of cur-
rently underutilized information that can be used to accelerate the systematic review process and iden-
tify gaps where future research should be focused.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Systematic reviews are the bedrock of evidence-based medicine
(EBM), however the time required to conduct a review can be
extensive (taking ﬁve or six people more than 1000 h to complete
[1]), which can cause delays between when an experimental result
is published and when those results are integrated into clinical
practice. The systematic review process is fundamentally an infor-
mation organization activity comprising of information retrieval,
extraction, and analysis [2]. The increased availability of electronic
abstracts and full text articles have led to several automated meth-
ods to accelerate the process, where most systems focus on the
information retrieval stage [3–8] and to some extent, the informa-
tion extraction stages [2,9]. In addition to strategies that operateover published literature, manual efforts have been proposed to
capture data required in a systematic review [10,11]. The approach
presented in this paper augments these efforts by leveraging a cur-
rently underutilized resource that occurs in scientiﬁc articles– the
direct comparison sentence.
The idiom ‘‘you should not compare apples to oranges’’ under-
scores the common practice of only comparing entities that are
of the same type. This practice in common language usage also
appears in scientiﬁc articles, such as in sentence 1, where we learn
that the endpoint uterine weights was used to compare the two
entities the TAM group (TAM in this article refers to Tamoxifen)
and controls. The article from which this sentence was drawn also
provides information about the dosage and duration of the TAM
treatment and the type of animals used in the control group that
may be necessary to contextualize the experimental results, but
this single short sentence alone provides a succinct summary of
one of the experimental ﬁndings.
C. Blake, A. Lucic / Journal of Biomedical Informatics 56 (2015) 42–56 43(1) In the present study, uterine weights[endpoint] of intact ani-
mals treated with TAM[agent] was decreased as compared with
controls[object], although not signiﬁcantly. 12189200
Although comparative sentences provide a wealth of informa-
tion, from a linguistic perspective these sentences have earned a
reputation for being ‘‘notorious for its syntactic complexity’’ [12]
and ‘‘very difﬁcult’’ to process automatically [13]. Despite these
challenges, the densely packed information contained in a compar-
ison sentence have been used to identify aspects about products
that customers prefer or dislike [14,15]. Similarly, there has been
some work on comparatives in biomedical literature. For example
one study focused on comparative sentences from MEDLINE
abstracts that contained two drugs [16]; however, such a strategy
would not consider sentence 1 because only one drug is men-
tioned. Comparing a drug to a placebo or control group is common
in clinical trials, a practice that lead the comparative effective
research (CER) community to call for more head-to-head trials
[17]. Although adding a placebo entity type to the set of required
entities in the earlier approach would alleviate this immediate
issue, this ﬁx does not mitigate against the need to decide the enti-
ties a priori. Our results show that authors use a range terms when
describing the entities being compared, which would be very difﬁ-
cult to specify in advance.
In this paper, we present an automated process that identiﬁes
two entities (the agent and object) that are compared with respect
to a given endpoint. The approach uses sentence structure, which
removes the need for a user to provide a set of entities in advance,
and minimizes the impact of errors during entity recognition.
Moreover, this approach enables the results from the system to
be used in domains where the entities of interest are unknown.
With respect to the clinical domain, removing the need to deﬁne
entities a priori means that the method presented here will work
for both drug-placebo and head-to-head studies.
In addition to focusing on sentence structure, the automated
approach presented here extends earlier work in biomedicine by
providing system predictions at the noun phrase rather than sen-
tence level. Consider an earlier study where semantic and syntactic
features were used with three classiﬁers (Naïve Bayes, Support
Vector Machines and a Bayesian network) to differentiate compar-
ison from a non-comparison sentences [18]. The system described
in this paper identiﬁes the speciﬁc noun phrases that ﬁll the agent,
object and endpoint roles. Thus the system would identify TAM
from sentence 1 as the agent control as the object, and uterine
weights as the endpoint.
Our goal in this paper is twofold. First, we describe a two-step
automated process that leverages direct comparative sentences.
The system is evaluated using more than 2 million sentences from
full-text articles that appear in a sample of full-text articles in
three journals: Diabetes, Carcinogenesis, and Endocrinology.
Second, we provide a situated evaluation to illustrate how the
facets that are extracted from comparison sentences can be
employed to support the systematic review process. We did not
select the focus of the situated evaluation in advance, but rather
the focus emerged from the entities identiﬁed by the system. The
situated evaluation of diabetes treatments provides insight into
how the system would perform when embedded into the existing
systematic review process.
1.1. Deﬁnitions
The system described in this paper identiﬁes noun phrases that
capture two entities that are being compared (called the agent,
object) and the way in which those entities are compared (called
the endpoints). This terminology borrows the agent and objectterminology from the comparative claim described in Blake’s
Claim Framework [19], but we use endpoint rather than the basis
of the comparison (or aspect) to capture how the entities are com-
pared. This section provides the critical elements of a direct com-
parative sentence.
Comparative sentences are either gradable or not gradable.
Gradable sentences enable the reader to order entities, for exam-
ple the TAM group is lower than the control group with respect to
uterine weight in sentence 1. In contrast, a non-gradable compar-
ison does not provide enough information to order the reported
entities, such as in sentence 2 where tamoxifen and
4-hydroxytamoxifen cannot be ranked with respect to uterine
weight. Non-gradable sentences are further characterized as simi-
lar or different, where sentence 2 is a similar type of non-gradable
comparison.
(2) Since tamoxifen[agent] and 4-hydroxytamoxifen[object] had
nearly identical effects on uterine weight[endpoint], this
indicates that only a small proportion of the administered
4-hydroxytamoxifen reached the uterus. 10190564Deﬁnition 1. Direct comparison sentences capture either gradable
or non-gradable comparisons.
In addition to requiring that sentences be either gradable or
non-gradable, a direct sentence comparison must include entities
that play the role of an agent and an object as deﬁned in Blake’s
Claim Framework [19]. Consider sentence 3 where two endpoints
as well as the object of the comparison are explicitly mentioned
but the sentence does not mention the agent. This sentence is con-
sidered out of scope because it does not contain an entity that
plays the agent role. Agents and objects are typically different noun
phrases, but in some sentences a single noun phrase can play both
roles.
(3) LPO levels[endpoint] were slightly (596 ± 89 nmol/mg pro-
tein), but not signiﬁcantly (P > 0.05) different from the normal
group[object], and GSH levels[endpoint] remained signiﬁcantly
decreased (P < 0.02 vs. normal) (Fig. 1A and B). 12606525Deﬁnition 2. Direct comparison sentences include entities that
play an agent and object role.
We are particularly interested in how entities are compared. For
example the non-gradable comparison sentence shown in 4 pro-
vides noun phrases for the agent (men) and the object (women)
roles, but does not provide information about how the authors
established that men and women responded differently to hypo-
glycemia. Although this sentence may be useful to infer semantic
types (i.e. that men and women have the same semantic type),
the sentence does not contain an endpoint and thus would not
be included in the system summary.
(4) Men[agent] and women[object] respond differently to an
acute bout of hypoglycemia. 12829642Deﬁnition 3. Direct comparison sentences include information
about how entities were compared (the endpoint).
It is quite common for an author to report more than one com-
parison in the same sentence, such as in sentence 5 that ﬁrst com-
pares bazedoxifene with ethinyl estradiol and then compares
bazedoxifene with raloxifene. The system should identify all noun
phrases that play the agent, object or endpoint roles from each
sentence.
Fig. 1. Raw and syntactic distances for the sentence ‘‘In this RBA assay, raloxifene exhibited the highest afﬁnity for Eralpha relative to estradiol’’ in pmid 10579349.
44 C. Blake, A. Lucic / Journal of Biomedical Informatics 56 (2015) 42–56(5) In an immature rat uterine model, bazedoxifene[agent] (0.5
and 5.0 mg/kg) was associated with less increase in uterine
wet weight[endpoint] than either ethinyl estradiol[object]
(10 lg/kg) or raloxifene[object] (0.5 and 5.0 mg/kg). 15961563
Similarly, authors may include additional information on how
agents and objects were compared, such as in sentence 6, where
the system should report all four endpoints.
(6) Treatment with toremifene[agent] (all doses) or tamox-
ifen[agent] (1 and 10 mg/kg) for 28 days produced a decrease
(P < 0.05) in overall uterine size[endpoint] and myometrial thick-
ness[endpoint]; however, uterine luminal[endpoint] and glandular
epithelia cell height[endpoint] increased (P < 0.05) compared with
control[object]. 10719842
Our goal is to identify the study results and the Deﬁnitions 1–3
generally fulﬁlled that goal, but our analysis throughout this pro-
ject did reveal a few exceptions to this rule, as is demonstrated
by sentence 7, which contains the agent, object and the endpoint,
but does not actually provide the result of the comparison. At this
point the system does not include constraints to ensure that the
direct comparative sentences provide results, however we have
evaluated the extent to which such constraints are necessary
empirically by measuring the number of non-results sentences.
(7) In two recent studies with type 2 diabetic patients, the
effects of the PPARgamma agonist troglitazone[agent] on insulin
signaling[endpoint] and action[endpoint] were therefore compared
with the effects of metformin[object]. 12196460Deﬁnition 4. Direct comparison sentences provide the result of
the comparison.To summarize, a direct comparison sentence includes at least
one noun phrase that ﬁlls each of the following roles: agent, object,
and the way in which the agent and object are compared (the end-
point). The sentence must be either gradable or non-gradable and
report the result of the comparison. Any sentence that does not
conform to these deﬁnitions is out of scope.
2. Related work
The idea of automating the systematic review process was ﬁrst
introduced a decade ago when the process was described as selec-
tion, extraction and analysis [2]. Much of the research since then
has focused on informatics tools that support the selection (infor-
mation retrieval) stage of the process [3–7] with some work on the
extraction stage [2,9]. In addition to the purely automated strate-
gies, efforts that combine human and computational tools have
also been explored [10,11]. The approach presented in this paper
extends these efforts to focus on the extraction and analysis stages
of the systematic review process. Our approach also leverages a
currently underutilized resource that occurs in scientiﬁc articles–
the direct comparison sentence.
Despite the complexity of comparative structures, several com-
putational methods have been proposed to identify comparison
sentences and elements of a comparison sentence. Much of the
work operates over customer reviews, forum posts and news arti-
cles, and combines opinion mining and sentiment classiﬁcation to
characterize user satisfaction with different aspects of a product.
Keywords and cue phrases were found to be effective features for
separating comparative from non-comparative sentences espe-
cially with regard to gradable comparisons [14–16,18]. One
improvement over keywords was achieved by introducing Class
Sequential rules which met the minimum conﬁdence threshold,
manual rules as well as application of data mining classiﬁcation
over the rules to separate comparative from non-comparative sen-
tences in a collection that consisted of consumer reviews, news
articles and forum discussions [14,15]. This work was
C. Blake, A. Lucic / Journal of Biomedical Informatics 56 (2015) 42–56 45subsequently extended to extract comparative relationships from
the sentences.
Researchers have also examined the importance of subject
claims with regard to new government’s regulations and the sub-
sequent effort to extract opinions from the host of comments about
the proposed regulations. It has been recognized that a large
amount of comments that are generated in response to a new pro-
posed regulation requires the development of a classiﬁcation tool
that can recognize subjective claims in an automated way [20]. A
supervised machine learning method that used lexical and syntac-
tic features was used to summarize the main idea from the com-
ments in relation to whether the comment supports, opposes, or
proposes a new idea.
In biomedicine, however, only a handful of studies explore com-
parative sentences. One of the earliest studies considered clinical
trial abstracts from MEDLINE [16]. The system used SemRep [21]
to identify concepts from each sentence and semantic constraints
were applied to identify sentences that contained two entities in
the Uniﬁed Medical Language System (UMLS) that had a semantic
types of pharmacologic substance, antibiotic, or immunologic fac-
tor. The system then differentiated comparative sentences from
other sentences in the abstract. This strategy does not recognize
non-scalar or non-gradable comparative constructions [22],
whereas the method presented in this paper includes both grad-
able and non-gradable comparisons. We also consider the full text
of an article rather than just the abstracts and demonstrate how
the comparison facets from multiple documents can be utilized
and presented to directly support the systematic review process.
A similar study focused on identifying coordinating constructions
from an article as a way to identify pharmacological intervention
arms in randomized controlled trials (RCTs) [23]. Similar to [16],
this work requires that the two entities that are being compared
are pharmacological interventions. As already mentioned, our
work is not restricted by the use of a named entity recognizer or
to any particular intervention.
An analysis of clinical questions in the National Library of
Health (NLH) Question Answering Service (http://www.clinicalan-
swers.nhs.uk) revealed that 16% of the 4580 questions referred to
direct comparisons of different drugs, treatment methods and
interventions [22]. The clinical questions involved comparisons,
but the information retrieval system provided abstracts. In con-
trast, the noun phrases predicted by the system presented in this
paper lends itself to the tabular summaries created in systematic
reviews, where results from multiple different studies are pre-
sented as a table.
The work most closely related to this paper introduced a set of
sentence features that could be used to differentiate comparative
from non-comparative sentences in full-text articles [18]. The fea-
tures were used by three classiﬁers (Naïve Bayes, Support Vector
Machines and a Bayesian network) which resulted in an F1-score
for comparative sentences of 0.71, 0.69 and 0.74 respectively. We
extend that work by extracting the speciﬁc nouns and noun
phrases that are being compared (the agent and object) and the
way in which the entities are compared (the endpoint) rather than
providing sentence level predictions.
Identifying comparisons has also been explored from a rhetori-
cal standpoint that situates a scientiﬁc article within the research
community. In particular, the comparison claim type is similar to
the Create a Research Space (CARS) model, which includes estab-
lishing a niche phase where an author counter-claims to establish
a research gap [24], as well as the Rhetorical Structure Theory that
includes a contrast schema and antithesis relation that are then
used between different nucleus and satellite clauses [25].
Comparisons have been mentioned in these earlier study of physics
articles where authors compare their results with previous exper-
imental results (see Sections 4.3 and 8.1 in [26]), which is alsomirrored in Teufel and Moen’s contrast category, which includes
the action lexicon, better_solution, comparison and contrast [27].
In contrast to these models, our comparisons focus on the results
of an empirical result rather than how those results relate to the
existing research community.
There has been considerable effort to automatically identify
binary relationships from text such as drug A treats drug B
[28,29] where drug A and drug B are arguments to the predicate
treats. Similarly there have been efforts to identify the ontological
isa relationship in order to extend taxonomies [30], where again
the triple reﬂects binary arguments to the predicate isa. Although
it may be useful for a new user to a ﬁeld to identify the set of drugs
used to treat a particular condition, expert scientists and informed
consumers need more detailed information about how drugs com-
pare. The tabular summary (see Section 4.3.4) can also be concep-
tualized as a triple, where the agent and object entities are
measured with respect to a given endpoint, but the way in which
drugs are measured is not a predicate, but rather provides the
experts writing the systematic review with insight into the speciﬁc
way that interventions are measured and compared.3. Materials and methods
A two-step process is used to identify facets from direct com-
parative sentences. First, candidate comparative sentences are
identiﬁed from a collection of full-text scientiﬁc articles and then
entities that fulﬁll the agent, object or basis of the comparison
are identiﬁed using machine learning. Prior to steps 1 and 2, full
text articles were pre-processed from the TREC collection [31] to
identify sections and sentences, and the dependency parse of each
sentence was generated using the Stanford Parser version 3.2 [32].3.1. Step 1 – Identify comparison sentences
Cuewords and phrases are good predictors of a comparative sen-
tences. This work extends the 35 features described in [18], where
comparative sentenceswere identiﬁed using three different classiﬁ-
cation algorithms: Naïve Bayes, Support Vector Machines and a
Bayesian network. We also considered using a machine learning
approach during the ﬁrst step, but found that the accuracy was suf-
ﬁcient without an additional layer of training (see results in
Section 4.1). A sentence that contains any of the patterns described
below ismarked as a comparison sentence and thenpassed to step 2.
Candidate comparative sentences were identiﬁed using a col-
lection of adjectives and lexico-syntactic patterns. Earlier work
suggests that comparison phrases (such as compared with) provide
good recall (98%), but the resulting precision can be low (32%) [15].
Recall is much more important than precision in this setting
because candidate sentences identiﬁed from the ﬁrst step are sub-
sequently processed using machine learning to identify the speciﬁc
role that each noun plays in the comparison. Thus the operational
system would be tuned for optimal recall during step 1 and then
for optimal precision in step 2 where sentences that do not contain
a noun phrase that operate in all three roles (agent, object and an
endpoint) may be eliminated.
Verbs such as increase, or reduce are good indicators of a grad-
able comparative sentence. The system uses change terms from
[19], which includes the comparative agreement relation from
the SPECIALIST Lexicon from the Uniﬁed Medical Language
System (UMLS, umlsks.nlm.nih.gov, version 2011AB).
Sentences containing lexico-syntactic paths that include either
an UMLS adjectives, or the terms better, more, less, worse, fewer,
and lesser, followed by the preposition than were also tagged as a
candidate comparison sentence. Dependencies from the Stanford
Parser (version 3.2) [32] allow the system to detect candidate
46 C. Blake, A. Lucic / Journal of Biomedical Informatics 56 (2015) 42–56sentences where the preposition does not immediately follow the
adjective (or additional terms), as is illustrated in sentence 8 where
text diabetic subjects that ﬁlls the agent role occurs between the
words higher and than.
(8) Fasting glucose[endpoint] was higher in diabetic sub-
jects[agent] (168.8 ± 55.2 mg/dl) than in nondiabetic subjects
[object] (93.9 ± 9.6 mg/dl). 12882937
The previous lexico-syntactic paths work well for gradable
comparisons. An additional set of comparison transition phrases
were developed that work well for both gradable (such as com-
pared with) and non-gradable (such as similar to, different from)
comparative sentences. Each transition phrase (either adjective
or verb) has at least one corresponding preposition. For example,
different can be followed by either the preposition from or than.
Additional paths that include adverbial modiﬁer (advmod) or a
ﬁnite clause subordinate (mark) were also used with the preposi-
tion than. See Fig. 3 for the additional constrains that are applied
to sentence that contains one or more of the cue phrases described
above, before being processed in step 2.
3.2. Step 2 – Identify roles
Machine learning is used to automatically determine the noun
phrases (entities) from a candidate comparative sentences that sat-
isfy the agent, object and endpoint roles. For example, in sentence
1, TAM, control and uterine weightswould be identiﬁed as the agent,
object and endpoint respectively. Entities in this system are gener-
ated automatically using the domain independent dependency
parser [32] (version 3.2). The system is provided with both single
words (raloxifene, ERalpha and estradiol in sentence 9) and complex
compound noun phrases (RBA assay and highest afﬁnity).
(9) In this RBA assay, raloxifene[agent] exhibited the highest
afﬁnity for ERalpha[endpoint] relative to estradiol[object]. 10579349
Two classiﬁers, the support vector machine (SVM) and general-
ized linear model (GLM) were built for each role. The Oracle Data
Miner (ODM, Version 3.2.20.09) implementation of the algorithms
were used, where the linear kernel and complexity factor of 0.167
was used with the SVM and a conﬁdence level of 0.95 was used
with the GLM based on our experience with the ODM in other
experiments [33].
Each classiﬁer is provided with the same set of features for the
same role. Twenty-six features are used in the agentmodel and good
performance for the object and endpoints was achieved using a sub-
set of twenty-one features. Features were informed by prior work
(see related work) and a training set comprising 656 noun phrases
(in 100 sentences) that were drawn from three different full-text
journals (Diabetes, Carcinogenesis and Endocrinology). Most features
can be grouped into one of the following anchor categories.
A. Change anchors are typically associated with gradable com-
parisons, such as minimize, lose and accelerate. The system
uses a lexicon of 770 verbs that were modiﬁed from [19].
B. Comparison anchors such as similar to, different from, and
compared with identify both gradable and non-gradable
comparisons. The system uses 65 comparison transition
phrases that were modiﬁed from [18]. Within this set, the
system distinguishes between two types of comparison
anchors. Type Bi comparison anchors occur when the ﬁrst
word in the phrase is immediately followed by the preposi-
tion (i.e. there is no gap between the ﬁrst word in the phrase
and the preposition such as in sentence 1). Type Biicomparison anchors occur when the ﬁrst word in the phrase
is immediately followed by the noun (i.e. there is a gap
between the ﬁrst word and the preposition such as in sen-
tence 8).
C. Evidence anchors are verbs that indicate a ﬁnding. The sys-
tem used a set of 432 evidence-based verbs such as acknowl-
edge, result, imply, view, ﬁnd, illustrate that were created for
this experiment.
The change (A) and comparison (Bi,Bii) anchors have been
explored in the comparative mining. In contrast, the evidence
anchors (C) have been explored with respect to scientiﬁc rhetoric
[27] but evidence terms have not been explored with reference
to identifying entities (the agent and object) in the contexts of
how the entities are compared.
The ﬁrst set of features measure the raw and syntactic distance
between each candidate noun and the change, comparison and evi-
dence anchors. Raw distance is the number of words that occur
between a noun phrase and the anchor. Sentences containing more
than one anchor of the same type, are assigned the distance to the
closest anchor and values of 1000 are assigned to sentences with-
out an anchor. Type Bi and Bii are captured separately for raw dis-
tance, thus there are eight features that capture the raw distance
before and after each anchor, which are used in all three classiﬁers
(agent, object and endpoint).
Unfortunately, raw distance is sensitive to the number of words
in a noun phrase and conjunctive clauses, which are frequently
employed in technical writing. For example, in sentence 6 the
raw distance between the noun phrase glandular epithelia cell
height and the change anchor decrease is 3 more than if an abbre-
viation were used for this entity, even though the term would ﬁll
the endpoint role in either case. Similarly, the distance between
each of the endpoints and the object control varies because the
basis of the comparison is reported as a list. Syntactic distance
employs the dependency representation of a sentence to mitigate
against the raw distance limitations, where syntactic distance is
the number of nodes between the head noun of a noun phrase
and each anchor that appears in the same branch of the depen-
dency tree. Thus the syntactic distance would have the same value
for each of the basis of the comparisons in sentence 5. As with raw
distance, the minimum distance is used if multiple anchors of the
same type are used in a sentence.
Fig. 1 shows the syntactic dependencies generated from sen-
tence 9 that contains the evidence anchor exhibited. The syntactic
distance between each of the following nouns RBA assay, raloxifene,
afﬁnity, Eralpha, and estradiol and the root of the sentence exhibited
is 2, 1, 1, 1, and 3 respectively. In addition to the evidence anchor,
the noun phrase that fulﬁlls the object role in this sentence (estra-
diol) has a syntactic distance of 1 with respect to the comparison
anchor relative to. None of the other noun phrases occur in the
comparison anchor branch of the dependency tree and would thus
be assigned a distance of 1000. The second set of features capture
the syntactic distance between the each noun phrase and each of
the anchors (one for type A, Bi, Bii and C). These features are used
in each classiﬁer (SVM and GLM) for all three roles (agent, object
and endpoint).
The third set of features also employs the dependency structure,
but rather than use the numerical distance, categorical features are
used to capture the dependency path between a noun phrase and
each anchor. For example, the path between the endpoint RBA
Assay and the evidence anchor is pobj/prep. Similarly the path
between the agent raloxifene and the evidence anchor is nsubj. To
avoid over-ﬁtting, two additional categorical features were
included, one that captures the ﬁrst 2 syntactic dependencies from
the anchor and anther that captures the ﬁrst 3 syntactic dependen-
cies from the anchor. A total of six categorical features capture the
Aobserved
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twofold
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increase
auxpass
pobj
nsubjpass
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Fig. 2. Syntactic structure of the sentence of sentence (10).
Table 1
Summary statistics from three full-text journals.
Journal Articles Sentences Candidate
sentences
Noun phrases
avg. (min, max)
% candidate
sentences
Diabetes 2142 426,694 23,088 8 (2, 35) 5.41
Carcinogenesis 1958 394,835 20,051 8 (2, 58) 5.01
Endocrinology 5100 1,194,114 63,995 8 (2, 46) 5.35
Total 9200 2,015,643 107,134 5.31
Sentences with 1 or 2 comparison
anchors, 62 change anchors
and 640 words
86,864 4.31
C. Blake, A. Lucic / Journal of Biomedical Informatics 56 (2015) 42–56 47syntactic path between the root of the syntactic tree and each can-
didate noun phrases and each of the anchors (A, B or C).
(10) A twofold increase in ALT activity[endpoint] was observed
in serum from diabetic rates[agent] compared with the lean con-
trols[object]. 15277384
The fourth set of features capture words that occur immediately
before and after each noun phrase in the sentence, and the ﬁfth
feature (isLeaf), is set to true when the noun or noun phrase
appears as a terminal node in the syntactic tree (a leaf). For exam-
ple, in sentence 10 the head noun controls is not a leaf node but
isLeaf is set to true because the modiﬁer lean is a leaf. In contrast,
isLeaf would be false for the noun serum (see Fig. 2).
The 21 features described thus far were used in each of the SVM
and GLM classiﬁers to classify nouns that ﬁlled the endpoint or the
object roles. Initial experiments with the agent role suggested that
an additional ﬁve features would improve performance (for a total
of 26 features). Analysis of the 100 sentences in the training set
revealed that agent noun phrases were frequently a nominal sub-
ject in a sentence. The nominal subject feature is set to true when
the dependency path contains a nominal subject (nsubj) and the
noun is close to the evidence term (the syntactic distance after
an evidence term is less than or equal to two). The boolean comple-
ment feature is set to true when the noun is part of a clausal com-
plement (where nouns are more likely to be agents). Nouns that
occur near a comparison transition anchor are more likely to be
objects. A feature (isFarFromComp) is set to true when the raw dis-
tance between the noun and the comparison anchor was greater
than 20 in order to hone in on nouns that play an agent role.
Lastly, two features that capture when the noun occurs between
the comparison transition and the subsequent preposition are
included in the agent model.4. Results and discussion
Standard measures of precision and recall were used to evaluate
steps 1 and 2, and accuracy and F1 measures were also calculated
for step 2; however step 1 is evaluated with respect to sentences
and step 2 is evaluated with respect to noun phrases. A situated
evaluation was then conducted that better reﬂects the systematic
review context in which the system would be used and the tabular
summary illustrates how the facets extracted by the system can be
used to accelerate the systematic review process and identify areas
where future work may be necessary.
4.1. Step 1 – Identify comparison sentences
Candidate sentences were identiﬁed using the method outlined
in Section 3.1 from more than 2 million sentences from full-text of
the articles published in the journals Diabetes, Carcinogenesis, and
Endocrinology. The journal Diabetes had the greatest proportion ofcomparative sentences (23,088 sentences, 5.41% of the total collec-
tion). Carcinogenesis had a slightly smaller number of candidate
comparative sentences but almost the same proportion of compar-
ative sentences (20,151, 5.01% of the total collection), and
Endocrinology had the largest overall number of sentences because
more articles were available (63,995 sentences, 5.35% of the total
collection). As Table 1 indicates, 5.31% of sentences in the collec-
tion were identiﬁed as candidate direct comparatives, which is
consistent with 5.11% reported in prior work [19].
Direct comparative sentences from all three journals were sim-
ilar with respect to the number of noun phrases, which was 8 on
average. The number of words (as opposed to noun phrases shown
in Table 1) in the direct comparisons ranged between 5 and 129.
We considered removing sentences that contained fewer than
three noun phrases, but some sentences used the same noun
phrase to describe both the agent the endpoint so only sentences
that contained 1 noun phrase were removed (Table 1 shows totals
after the 1 noun phrase sentences had been removed).
The number of comparison anchors varied between 1 and 8, and
the number of change anchors was between 0 or 1 and 12. A closer
inspection of sentences that contained many comparison anchors
and change anchors revealed that many were not direct compar-
isons, thus only sentences that contained 1 or 2 comparison
anchors and 0, 1 or 2 change verbs were considered in subsequent
steps, which was the majority of the candidate sentences
(102,260/107,134, 95.5%).
With respect to sentence length, candidate comparative sen-
tences drawn from Diabetes and Carcinogenesis contained an aver-
age of 30 words and sentences from Endocrinology had an average
of 29 words, which is longer than sentences in news stories which
have on average 23.4 words [34]. Sentences were further con-
strained to include 40 or fewer words, which again was the major-
ity of sentences (89,355/107,134, 83%). Applying both the number
of change and comparison anchors and sentence length constraints
resulted in 86,864 (81%) candidate comparative sentences that
were considered in step 2.
A training set of 100 sentences and a test set of 132 sentences
were selected from the 86,864 sentences that satisﬁed the con-
straints listed above (see Fig. 3). The accuracy of step 1 was estab-
lished by randomly selecting 1000 from the 86,632 sentences that
were not part of the training and test sets. Out of 1000 sentences,
866sentencesweredirect comparative sentences, thus theprecision
of step 1 is 86.6%. Establishing recall is difﬁcult when such a small
proportion of sentences (5.31%) contain a direct comparative, so
recall is explored using a situated evaluation described in
Section 4.3.4.2. Step 2 Evaluation – Role classiﬁcation performance
None of the previous work annotated comparison sentences
from full-text biomedical articles at a noun phrase level so an
existing annotated corpus could not be used so the authors created
1.91 million 
Sentences
Evaluate using 
1,000 sentences 
drawn at random
2.01 million 
sentences 
(9,200 full-text 
articles) 
in Endocrinology 
Diabetes, and 
Carcinogenesis.
No 86,632 
sentences
86,864 
Sentences
See 
Step 2
Training Set 
(100 Sentences)
Test Set 
(132 sentences)
<=40 words
<=2 change and 
>=2 comparison 
anchors
20,270
Sentences
No
Yes
107,134
Sentences
Ye
s
>=1 
constraint 
in step 1
Fig. 3. Experimental design for step 1.
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sentences, the models created in step 2 predict the speciﬁc role
(agent, object or endpoint) of each noun phrase and are thus eval-
uated at a noun phrase level. For example in step 2 the system
must identify all (and only) the noun phrases that satisfy a partic-
ular role, even when a sentence contains more than one noun
phrase for a particular role.4.2.1. Overall model performance
A training set of 656 noun phrases (in 100 sentences) was anno-
tated by both authors. Differences between annotators were dis-
cussed until agreement was reached on the role a noun phrase
played in the sentence as well as on the boundary of the noun
phrase. The features were established using prior work and anno-
tations in the training set. A test set of 936 noun phrases was cre-
ated by selecting 132 sentences at random from the 86,764Fig. 4. Experimental design for step 2.
Table 2
Training set results showing 95% conﬁdence intervals.
Agent Endpoint
GLM SVM GLM
Precision 0.50 (0.46, 0.54) 0.59 (0.55, 0.63) 0.57 (0.53, 0.
Recall 0.75 (0.72, 0.78) 0.96 (0.94, 0.98) 0.84 (0.81, 0.
F1 measure 0.60 (0.56, 0.64) 0.73 (0.70, 0.76) 0.68 (0.64, 0.
Accuracy 0.79 (0.76, 0.82) 0.85 (0.82, 0.88) 0.82 (0.79, 0.
Table 3
Test set results showing 95% conﬁdence intervals.
Agent Endpoint
GLM SVM GLM
Precision 0.38 (0.35, 0.41) 0.38 (0.35, 0.41) 0.40 (0.37, 0.
Recall 0.63 (0.60, 0.66) 0.58 (0.55, 0.61) 0.69 (0.66, 0.
F1 measure 0.47 (0.44, 0.50) 0.46 (0.43, 0.49) 0.51 (0.48, 0.
Accuracy 0.72 (0.69, 0.75) 0.73 (0.70, 0.76) 0.71 (0.68, 0.candidate sentences identiﬁed in step 1 that were not part of the
training set (see Fig. 4 for the experimental design used in step 2).
The classiﬁcation models created for the training set were then
applied to the test sentences. Three different support vector
machine (SVM) and generalized linear models (GLM) were built,
one for each role: agent, object and endpoint. The classiﬁcation
performance of the SVM was better than the GLM on the training
set with respect to all measures, precision, recall, F1 measure,
and accuracy for all three facets (see Table 2).
As with the training set sentences, the SVM model outper-
formed the GLM model in the test set, but the overall results for
agent and endpoints were lower in the test than the training set
(see Table 3). Despite the additional features, all metrics except
for GLM accuracy had lower performance when predicting the
agent role. Performance for the object was similar to the training
set, but the 0.05 difference between the GLM and SVM models in
the training set was reduced to 0.01 in the test set. The GLM and
SVM models showed similar performance for all roles.
Technical writing, such as the prose in scientiﬁc articles is more
difﬁcult to read than non-technical writing such as news stories, in
part because the sentences are longer and thus tend to have more
clauses and more noun phrases. In order to see the impact of sen-
tence length on the system performance, the test sentences were
partitioned into short (containing 30 or fewer words) and long sen-
tences that contain more than 30 and less than or equal to 40
words (see Tables 4 and 5).
Sentence length had little impact on accuracy, where perfor-
mance dropped by 0.05, 0.02, and 0.01 for the agent, endpoint
and object respectively. However, there was a drop in F1 perfor-
mance (0.16) for both the agent and endpoint models and a small
drop in F1 performance for object prediction (0.01). Long sentences
appeared to have had a greater negative effect on the GLM models
than the SVM models.Object
SVM GLM SVM
61) 0.67 (0.63, 0.71) 0.66 (0.62, 0.70) 0.78 (0.75, 0.81)
87) 0.94 (0.92, 0.96) 0.91 (0.89, 0.93) 0.99 (0.98, 1.00)
72) 0.78 (0.75, 0.81) 0.76 (0.73, 0.79) 0.87 (0.84, 0.90)
85) 0.88 (0.85, 0.91) 0.90 (0.88, 0.92) 0.95 (0.93, 0.97)
Object
SVM GLM SVM
43) 0.42 (0.39, 0.45) 0.78 (0.75, 0.81) 0.74 (0.71, 0.77)
72) 0.64 (0.61, 0.67) 0.75 (0.72, 0.78) 0.8 (0.79, 0.81)
54) 0.51 (0.48, 0.54) 0.76 (0.73, 0.79) 0.77 (0.74, 0.80)
74) 0.73 (0.70, 0.76) 0.92 (0.90, 0.94) 0.91 (0.89, 0.93)
Table 4
Test set results for short sentences (630 words) showing 95% conﬁdence intervals.
Agent Endpoint Object
GLM SVM GLM SVM GLM SVM
Precision 0.49 (0.44, 0.54) 0.46 (0.41, 0.51) 0.50 (0.45, 0.55) 0.51 (0.46, 0.56) 0.80 (0.76, 0.84) 0.77 (0.73, 0.81)
Recall 0.70 (0.65, 0.75) 0.63 (0.58, 0.68) 0.76 (0.72, 0.80) 0.69 (0.64, 0.74) 0.79 (0.75, 0.83) 0.83 (0.79, 0.87)
F1 measure 0.58 (0.53, 0.63) 0.53 (0.48, 0.58) 0.60 (0.55, 0.65) 0.59 (0.54, 0.64) 0.79 (0.75, 0.83) 0.80 (0.76, 0.84)
Accuracy 0.76 (0.72, 0.80) 0.75 (0.71, 0.79) 0.72 (0.68, 0.76) 0.73 (0.69, 0.77) 0.92 (0.89, 0.95) 0.92 (0.89, 0.95)
Table 5
Test set results for long sentences (>30 and 40 words) showing 95% conﬁdence intervals.
Agent Endpoint Object
GLM SVM GLM SVM GLM SVM
Precision 0.30 (0.26, 0.34) 0.33 (0.29, 0.37) 0.32 (0.28, 0.36) 0.35 (0.31, 0.39) 0.76 (0.72, 0.80) 0.71 (0.67, 0.75)
Recall 0.56 (0.52, 0.60) 0.55 (0.51, 0.59) 0.62 (0.58, 0.66) 0.59 (0.55, 0.63) 0.72 (0.68, 0.76) 0.77 (0.73, 0.81)
F1 measure 0.39 (0.35, 0.43) 0.41 (0.37, 0.45) 0.43 (0.39, 0.47) 0.44 (0.40, 0.48) 0.74 (0.70, 0.78) 0.74 (0.70, 0.78)
Accuracy 0.70 (0.66, 0.74) 0.72 (0.68, 0.76) 0.69 (0.65, 0.73) 0.73 (0.69, 0.77) 0.92 (0.89, 0.93) 0.91 (0.89, 0.93)
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to predict the object than the endpoint or agent across all measures
(precision, recall, F1 measure and the overall accuracy).
4.2.2. Interpolated precision and recall
The results presented in Section 4.2.1 employed thresholds
determined from the training set, but thresholds can be adjusted
to favor precision or recall. Fig. 5 shows the precision–recall curves
for object, endpoint and agent for the both the GLM and SVM
models. Features were created based on earlier work and the
training set, so the results shown in Fig. 5 should be interpreted
as an upper bound of system performance. The overall test set is
also shown, along with the results from the short and long
sentences in order to show how sentence length impacts system
performance. The precision reported is the highest precision at
each of the 11 recall levels i.e. P interpI = max r0 P p(r0) as deﬁned
in Ref. [35], p. 145.
Fig. 5 indicates that nouns fulﬁlling the object role are easier to
predict. The GLM and SVMmodels show similar performance, with
a maximum recall of 0.8 and a maximum precision of 0.8 for short
sentences. At the highest recall level (0.8), precision was 0.7 for
longer sentences using the SVM model. The application of GLM
model resulted in the highest recall level of 0.7 and the maximum
recorded precision of 0.8.
Compared to the interpolated precision–recall graph for object
identiﬁcation, the endpoint models show a drop in precision for
long sentences. For short sentences, the maximum precision at
the highest recall level (0.8) was 0.5 and with the all sentences
set, at the highest recall level (0.7), the maximum precision
recorded was 0.5. With the SVM model, the highest recall level
using the short sentences set was 0.7 and the maximum precision
achieved at this level was 0.5.
The agent role was the most difﬁcult comparison facet to
predict. Similar to the endpoint, the GLM model achieved a slightly
better performance on the short sentences set compared to SVM
model. The highest recall was 0.7 for short sentences, where the
maximum precision 0.5. Compared to SVM performance using
the same set the highest recall level was 0.6 and the maximum
precision 0.5. The overall set of test sentences had a maximum
precision at the highest recall level (0.6) of 0.4 in both the GLM
and SVM models. The agent role was the most difﬁcult to predict
in long sentences. The application of SVM model on this set
resulted in the highest recall level of 0.5 and the maximum
precision of 0.4. The GLM model applied on the overall test setresulted in the highest recall level of 0.6 and the maximum
precision of 0.3.
4.2.3. Error and feature analysis of step 2
A random sample of 90 noun phrases (30 agents, 30 objects, and
30 endpoints) from each predictive model for each journal (10 in
each journal for each of the three roles) were selected for further
analysis. The average recall for all three models was 0.85 and the
average precision was 0.58. A closer inspection of features that
played a major role in the model showed that both agents and end-
points are in close proximity to the change anchor, particularly for
gradable comparisons. However, because both agents and end-
points are near the change anchor, the predictive model incorrectly
labels some agents as endpoints and vice versa. The confusion
matrix in Table 6 shows that agent/endpoint misclassiﬁcation
caused all but 1 of the recall errors (an endpoint that was misclas-
siﬁed as an object).
With respect to precision, model results would need to be fur-
ther processed to identify the correct noun phrase in the 5 cases
where the model predicted an anaphoric reference, and in 3 cases
where the model predicted a noun phrase that introduced the
agent (see sentence 11 for an example). Complex sentence struc-
tures with multiple comparisons lead to 3 additional errors and
preprocessing errors at either a sentence or noun phrase level
caused an additional 9 errors in step 2. Lastly, 7 errors in step 2
were propagated from errors in step 1 (i.e. where a sentence was
incorrectly tagged as a comparison). Table 7 summarizes the root
cause of precision errors.
Several features contributed to the model. The six categorical
features that captured the syntactic path between the root of the
syntactic tree and the noun phrases were particularly informative,
where syntactic paths that were most indicative of an agent (from
the root of the tree) were passive nominal subjects, either a con-
junction or preposition following a nominal subject, a direct object
or a conjunction following a direct object and a direct object fol-
lowing a causal complement were the strongest features.
Syntactic paths that were indicative on an endpoint (again with
respect to the root of the dependency tree) were a nominal subject,
an open causal complement followed by a preposition, and a pas-
sive nominal subject followed by a preposition.
The object role was the easiest to identify, where noun phrases
that occurred between 1 and 5 words after the comparison anchor
were frequently objects, for example a sentence containing ‘‘com-
pared to the control group’’ would have a distance of 2. Object
Fig. 5. Interpolated precision and recall for object, endpoint and agent roles for the general linear model (GLM) and support vector machine (SVM) classiﬁers.
Table 7
Factors responsible for loss of precision in the SVM model.
Factors that inﬂuence precision Agent Endpoint Object
50 C. Blake, A. Lucic / Journal of Biomedical Informatics 56 (2015) 42–56noun phrases were also likely to be in a path that started with a
prepositional complement following the comparison anchors (pc
omp/pobj/dep/acomp/prep/pobj/conj, pcomp/pobj/prep/pobj/pre
p/pobj/advmod, or pcomp/pobj/prep/pobj/partmod/dobj) or that
started with a prepositional object (prep/pobj/prep/pobj/conj).
The presence of conjunctions found in these informative paths
highlights the complexity of sentences found in the genre of scien-
tiﬁc articles. The most informative syntactic path for the object
starting from the root of the sentence was prep/conj.Table 6
Error analysis of the SVM model for each agent, endpoint and object.
Actual Predicted Total Recall
Agent Endpoint Object
Agent 15 4 0 19 0.79
Endpoint 4 13 1 18 0.72
Object 0 0 24 24 1
Other 11 13 5 29
Total 30 30 30 904.3. Situated evaluation
The existing manual systematic review processes requires that
each team member extract facts from each article independentlyEndpoint identiﬁed as Agent or Object 4 1
Agent identiﬁed as Endpoint 4
Anaphoric reference 3 1 1
Introduces the role 3
Complex comparison structure 2 1
Preprocessing errors – sentence level 1 2
Preprocessing errors – noun phrase level 4 2
Not a full comparison 2
Not a comparison 2 4 1
Total errors 15 17 6
Precision 0.50 0.43 0.80
Step 1
Constraints
Direct comparisons: 9 out of 50 
System identified: 7 out of 9 
Step 1 Recall = 77.8%
Contains 
Metformin or 
a synonym
Yes
1,178 
Sentences
Sample 50 
sentences
Evaluate
Predicted comparisons: 78
Actual comparisons: 70
Step 1 Precision = 89.7%
Evaluate
2.01 million 
sentences 
(9,200 articles) 
in Endocrinology 
Diabetes, and 
Carcinogenesis.
Fig. 6. Situated evaluation design for step 1.
Fig. 7. Situated evaluation of step 2.
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would be tightly integrated into that manual processes, where
the system would make predictions that would then be veriﬁed
before moving into the analysis stage. Our goal in the situated eval-
uation is to demonstrate how facets from direct comparison sen-
tences provide insight into experimental endpoints. Once the
system evaluation reported in Sections 4.1 and 4.2 was complete,
the noun (and noun phrases) that played any role (object, endpoint
or agent) were ordered with respect to the number of times that
each phrase appeared. Metformin, an antidiabetic drug used to
treat diabetes, appeared frequently and thus became the focus
for this situated evaluation. The purpose of this evaluation is not
to measure the most frequent noun phrase in the sample of articles
that were in TREC because in a real systematic review much more
care would be required to ensure that articles from all the most rel-
evant journals were selected, but rather to explore the impact of
redundancy, to demonstrate that comparison facets can be
detected automatically without prior knowledge and to show
how the facets extracted from this system can be used to identify
areas where the literature agrees, disagrees and where there are
gaps.
4.3.1. Situated step 1 evaluation
To evaluate step 1, all candidate comparative sentences (a set
86,864 sentences, Table 1) containing either Metformin or the
brand names Glucophage, Glumetza, Fortamet, or Glucophage XR
were identiﬁed. Metformin appeared in 1178 sentences from all
three journals in the following forms: metformin, active metformin,
antecedent metformin treatment, intensive lifestyle metformin, met-
formin group, metformin mouse, metformin treatment, met-
formin-treated group, metformin-treated hepatocyte,
metformin-treated mouse, metformin-treated rat, metformin-treated
subject.
This situated example illustrates the gap between the way in
which a drug intervention is discussed in a scientiﬁc article and
the way in which a drug would be represented in an ontology.
Although you would expect metformin to be in a drug ontology
such as those in the Uniﬁed Medical Language System (UMLS), it
is unlikely that the phrase metformin-treated group would be cap-
tured. Similarly metformin-treated mice reﬂects a drug, an exper-
imental process, and a group and it would be odd to have the noun
phrase metformin-treated in a drug ontology. One of the other fre-
quent nouns that emerged from the test journals was diabetic,
which is in the UMLS, but nondiabetic is not in the UMLS and
nor should the latter term be added. These results suggest that
there is a gap between the terminology used to capture concepts
in an ontology and the terminology used in scientiﬁc discourse. It
is not just a question of domain coverage, but rather an inherent
issue of surface level differences (this phenomena is seen more
clearly with endpoints shown in Section 4.3.4).
A random sample of 50 sentences was drawn from the 1178
candidate sentences that contained at least one mention of
Metformin or a synonym (see Fig. 6). Of the 9 direct comparison
sentences found, the system correctly identiﬁed 7 providing a
recall of 77.8%. The two missed sentences (11 and 12) are shown
below.
(11) Fasting serum insulin concentrations[endpoint] decreased
signiﬁcantly and similarly during both rosiglitazone[agent] and
metformin therapy[object] by 4 ± 1 and 4 ± 2 mU/l, respectively
(Fig. 1). 15277403
(12) Water intake[endpoint] was randomly monitored through-
out the study, was found to increase in proportion to body
weight (r = 0.69, P < 0.001), and was not different among
treatment groups (0.093 ± 0.004, 0.098 ± 0.011, and0.098 ± 0.004 ml g1 day1 for control[agent], metformin-[agent],
and rosiglitazone-treated mice[object], respectively). 15983227
The proximity of the change and comparison anchor was
responsible for missing sentence 11, and the system appears to
have limitations when the author presents the results in complex
parenthetical structures. The remaining sentences contained
Metformin, but Metformin did not play an object, endpoint or
agent role in a comparison.
Further analysis was conducted to better understand how
redundancy in scientiﬁc articles would impact overall system per-
formance. All 1178 candidate comparison sentences from step 1
were searched and a total of 16 total sentences were found in
which Metformin played an object, endpoint or agent role but
the sentences were missed by the classiﬁer.
4.3.2. Situated step 2 evaluation
To evaluate step 2 the sentences in which the system predicted
that Metformin acted as an object, endpoint or agent were closely
inspected (see Fig. 7). Of the 73 sentences, 6 (8%) contained noun
phrases that ﬁlled the agent, object and endpoint, but did not actu-
ally report a result. No system constraints are currently in place to
remove non-result sentences, so this evaluation provides
52 C. Blake, A. Lucic / Journal of Biomedical Informatics 56 (2015) 42–56information about how much precision might be improved if such
constraints were in place. Eight additional sentences (13.7%) were
missing one of the comparison facets, which were necessary to
complete the tabular summaries in Tables 10–12. Metformin did
actually play a role in 56 of the sentences, providing a precision
in step 2 of 76.7%.
All 448 nouns phrases in the 56 sentences that the system iden-
tiﬁed and where Metformin did actually play a role were manually
annotated and compared with the system predictions. The results
(shown in Table 8) are consistent with experiments reported in
Sections 4.1 and 4.2, in that the comparison object was identiﬁed
with the highest precision (0.88) recall (0.88) and accuracy
(0.95). The SVM model achieved better performance than the test
set across all metrics and all facets (agent, endpoint and object).
This suggests that direct comparison sentences that it may be
easier to identify roles from sentences that include at least one
drug. The GLM model also performed better than the test set for
the agent and endpoint (with the exception of recall for the end-
point, which was 0.03 lower than the test set), however the GLM
model in the situated evaluation was not as good with respect to
predicting noun phrase that played an object role. The SVM model
outperformed the GLM model across all metrics.
In contrast with the earlier test results that differed by only
0.01, the differences between the GLM and SVMmodels were more
pronounced in the situated evaluation, but the differences were
still small, where accuracy differed by 0.02, 0.05 and 0.06 for the
agent, endpoint and object respectively. The SVM model provided
much higher F1 measures than the earlier test set for comparison
facets and the GLM model was higher for the agent and endpoint,
but about the same for the object. These differences in results may
be due to the smaller sample size of 448 noun phrases (in 56 sen-
tences) rather than 936 noun phrases (in 132 sentences) in the test
set, or the system may be leveraging regularities in how authors
compare drugs.
The system had incorrectly missed 16 sentences from step 1, so
we were curious about how much information was in the missing
sentences that was available in the noun phrases that were suc-
cessfully identiﬁed in both steps 1 and 2. Our analysis showed that
all of the information from 7 of the 16 sentences was in at least one
of the other 56 sentences that were retrieved by the system. The 9
missing sentences contained three variations on existing endpoints
(fat cell content, insulin release, and beta-cell function), two new end-
points (adiponectin, FFA concentrations), and two new agents or
objects (anti hyperglycemic drug PE and TZDs).Table 8
Situated evaluation in diabetes treatments showing 95% conﬁdence intervals.
Agent Endpoint
GLM SVM GLM
Precision 0.45 (0.40, 0.50) 0.50 (0.45, 0.55) 0.53 (0.48, 0.
Recall 0.65 (0.62, 0.68) 0.80 (0.77, 0.83) 0.59 (0.56, 0.
F1 measure 0.53 (0.50, 0.56) 0.62 (0.58, 0.65) 0.56 (0.53, 0.
Accuracy 0.77 (0.74, 0.80) 0.79 (0.76, 0.82) 0.78 (0.75, 0.
Table 9
Contingency tables for situated evaluation of agent, endpoint and object.
Agent Predicted Total Endpoint Pred
Yes No Yes
Actual Yes 74 18 92 Actual Yes 68
No 74 282 356 No 42
Total 148 300 448 Total 1104.3.3. Error and feature analysis of the situated evaluation
An error analysis was conducted for the Metformin situated
evaluation. Table 9 summarizes the false positives and negatives
for each model. The number of false negatives in the agent model
suggests that the threshold established with the training set could
be lowered to improve overall performance. In contrast, the end-
point model had a similar number of false positives and false neg-
atives, which suggests that the threshold was well set. The object
also had a good threshold.
As with the error analysis in Section 4.2.3, misclassiﬁed agents
and objects contributed to step 2 errors in the situated evalua-
tion, where noun phrases that played either an agent or endpoint
role appeared in the same sentence location. The general order of
the roles are agent-change anchor-endpoint,
endpoint-agent-change anchor, change anchor-endpoint-agent or
object-agent-endpoint. The same sentence structure can have
either an agent or an endpoint in the same place, so the current
set of features do not have enough discriminatory power to dis-
tinguish between these facets.
In several cases the model predicted an introductory clause of a
sentence rather than an agent endpoint, for example the agent
model incorrectly predicted ‘‘conclusion’’ instead of ‘‘intensive life-
style’’ for sentence 13 shown below. Removing such noun phrases
before running the model would be one strategy to resolve this
error, or adding additional post-processing that ﬁnds the following
clause may also help to alleviate this issue.
(13) In conclusion, intensive lifestyle intervention[agent]
reduced levels of nontraditional cardiovascular risk factors[end-
point] both relative to placebo[object] and to a lesser degree rela-
tive to metformin[object]. 15855347
Complex comparison structures also caused errors, particularly
when the main focus of the sentence was not a comparison rela-
tion. Consider sentence 14 where the main focus is a comparison
and sentence 15 that compares hepatic and renal responses before
and after treatment with metformin. Sentence 15 contains an addi-
tional claim that the antecedent metformin treatment did not have
any inﬂuence on the results. This additional information is supple-
mentary to the expression of the main comparison and as such
introduces more noise into the process of disambiguation of differ-
ent comparison facets that participate in the expression of a com-
parison relation.Object
SVM GLM SVM
58) 0.62 (0.58, 0.66) 0.75 (0.71, 0.79) 0.90 (0.87, 0.93)
62) 0.67 (0.64, 0.70) 0.75 (0.72, 0.78) 0.88 (0.86, 0.90)
59) 0.64 (0.61, 0.67) 0.75 (0.72, 0.78) 0.89 (0.87, 0.91)
81) 0.83 (0.81, 0.85) 0.89 (0.87, 0.91) 0.95 (0.94, 0.96)
icted Total Object Predicted Total
No Yes No
34 102 Actual Yes 91 12 103
304 346 No 10 335 345
338 448 Total 101 347 448
C. Blake, A. Lucic / Journal of Biomedical Informatics 56 (2015) 42–56 53(14) Interestingly, metformin[agent] (Fig. 2C) also inhibited
PTP[endpoint] opening with an efﬁcacy similar to that of
CsA[object]. 15983220
(15) Nevertheless, since hepatic and renal responses[endpoint]
observed in our subjects treated with metformin[agent] did not
differ from those not treatedwith it[object], an inﬂuence of antece-
dentmetformin treatment on our results seems unlikely. 12765948
One of the underlying premise of this work is that the funda-
mental unit of a comparison is a noun phrase, which is not always
the case. Consider sentence 16, where the agent really should be
the ‘‘mechanism by whichmetformin activates AMPK’’. The current
representation is inadequate to represent this agent. Similarly, the
object in sentence 16 is also a mechanism that includes multiple
noun phrases for the same entity, and would be approximated by
the system by selecting more than one noun phrase. These rela-
tionships are captured in the Claim Framework as agent, object
and endpoint modiﬁers, but modiﬁers are not implemented in
the current system.
(16) Although the mechanism by which metformin activates
AMPK remains unclear, it must be different from that of AICA
riboside, which acts by being converted to the AMP mimetic
agent, ZMP. 12145153Table 10
Tabular summary of endpoint variations used to measure how well diabetes interventio
and * means that the article stated that the difference was signiﬁcant.
Endpoint Pharmacological treatment
Rosiglitazone Troglitazone Metform
exenatid
Diabetes
Diabetes incidence rate T < M⁄ 15793255
Risk for type 2 diabetes
Development of diabetes T greater impact than
M 15793255
Insulin
Proinsulin concentrations
Insulin
Insulin action T⁄ > M
(improvement) 11756319
Insulin (concentrations) T similar to M
(decreased⁄) 11812753
Serum insulin concentrations R < ⁄ M 15277403
Insulin sensitivity T > ⁄ M
(improvement) 15793255
% suppression by insulin M < R 15277403
Glucose
Glucose T similar to M
(decreased⁄) 11812753
Fasting glucose
Hepatic glucose production
during hyperinsulinemia
M < R 15277403
Glucose disposal T greater efﬁcacy than
M 11756319
Glucose disposal (rate) T > M, P < 0.05 11812753
T > M 12606507
Serum fructosamine M & E re
alone 153
Glycated hemoglobin (HbA1c) T similar to M
(decreased⁄) 11812753
M & E re
alone 153Some system errors were caused by complex sentence struc-
tures, such as those that included use subordinating conjunctions,
correlative conjunctions, and discourse terms such as nevertheless,
moreover, however that authors use to describe nuanced experi-
mental results. The model does identify syntactic structures with
conjunctive clauses, however further pre-processing may help to
alleviate some of the errors. Sentence 17 shows an example of
how conjunctions can be layered within the sentence.
(17) Among all participants, including those who developed
diabetes, fasting glucose[endpoint], insulin[endpoint], and proinsulin
concentrations[endpoint] were signiﬁcantly lower than
placebo[agent] at the ﬁrst annual visit in the metformin[object]
and the lifestyle groups[object] and increased during the 2nd
and 3rd years, with the levels remaining signiﬁcantly lower
than in the placebo group (Fig. 2). 16046308
Sentence 17 contains 3 endpoints (fasting glucose, insulin and
proinsulin concentrations) that all must be identiﬁed by the sys-
tem to obtain perfect recall. In addition the sentence contains mul-
tiple objects (metformin and lifestyle groups) and again the object
classiﬁer would need to identify both noun phrases to achieve per-
fect recall. The real challenge comes with extracting the compar-
isons made for the 2nd and 3rd years and the implicit reference
to metformin in those comparisons. Lastly, this sentence highlightsns compare with Metformin in human studies. Numbers reﬂect pubmed identiﬁers
Lifestyle Placebo
in and
e
Metformin,
sulfonylurea
and exenatide
Diet and
exercise
D more effective⁄
14633845
M < placebo 16046308
M < ⁄ placebo 16046308
M < placebo 16046308
M < ⁄ placebo 16046308
M < ⁄ placebo 16046308
duces > M
31525
M, S & E reduces > M
alone 15331525
duces > M
31525
M, S & E reduces > M
alone 15331525
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but not extracted in this project.
4.3.4. Multi-document summary
Systematic reviews typically synthesize evidence based on the
same study design, such as randomized clinical trials in medicine
or different animals in toxicology. The medical subject headings
(MeSH) were collected for each of the 20 different articles that con-
tained the 56 veriﬁed Metformin sentences. All articles contained a
MeSH of either Humans (16 articles) or Animals (5 articles). One
article had both Humans and Animals, but the majority of the ﬁnd-
ings and experiments reported in that paper focused on animals so
the study was added to the Animals tabular summary.
Tables 10 and 11 show tabular summaries of endpoints
detected in human articles involving Metformin. Each table cell
in the summary provides the result with respect to a given end-
point (shown as rows) that were used to compare Metformin with
a given intervention (shown as columns). Columns 2–6 show drug
comparisons and columns 7–9 show non-drug interventions.
Endpoints identiﬁed by the system are listed in the leftmost col-
umn. The headings are abbreviated to just the ﬁrst letter in the
table cells, for example the T in row 1, column 2 refers to
Troglitazone. The rightmost column shows how Metformin com-
pares to a placebo or control group and shows that many of the
endpoints measured with Metformin are frequently compared
with placebo or control groups which is consistent with concerns
raised by the comparative effectiveness community [34].
The situated evaluation shows that in addition to measuring
diabetes directly, insulin and glucose levels are measured to eval-
uate Metformin with other interventions (see Table 10). The tabu-
lar summaries shows endpoints in the original form, except for
abbreviations where the full form of the abbreviation from theTable 11
Tabular summary of remaining endpoints used to measure how well diabetes interventions
means that the article stated that the difference was signiﬁcant.
Endpoint Pharmacological treatment
Troglitazone Rotenone C
(C
Phosphatidylinositol-4,5-bisphosphate
3-kinase (PI3K) activity
T > M 11812753
AKT activity T similar to
M 11812753
T different to
M 11812753
AMPK-activated protein kinase (AMPK)
alpha2
C-reactive protein (CRP) T > (reduction)
M 15855347
Complex I in human microvascular
endothelial cells (HMEC-1)
M mild inhibitor
compared with
R 15983220
Permeability transition pore (PTP)
opening
S
(i
Fibrinogen levels
Fat cells T larger⁄
M 11756319
Gene expression
Nontraditional cardiovascular risk
factors
Hepatic and renal responses
Nocturnal or postprandial lipolysis M has no effect (in
contrast to T) 12606508
Abdominal area
Medication adherence T > M 15793255article is shown in the table to aid in readability. It may be possible
for a system to automatically unify the endpoints, but we envision
that the domain expert who is responsible for the systematic
review would be directly involved in the decisions made concern-
ing which rates, concentrations, sensitivities and suppressions
should be combined. Because comparison sentences provide a den-
sely packed summary of results users may need to return to the
original article to determine which endpoints should be uniﬁed.
For example the diabetes incident rate shown in the ﬁrst row
should only be uniﬁed with the risk for type 2 diabetes in the sec-
ond row if the ﬁrst article also refers to type 2 diabetes. Although
the comparison sentence does not contain this information the sys-
tem maintains a link back to the original study so that a user can
accurately unify terms. In addition to the pubmed identiﬁer that
is shown in each cell of the tabular summaries in Tables 10–12,
the system maintains the speciﬁc sentence so that the user can
go directly to the section of the article where the claim was made
(space limitations prevented us from providing this additional
level of detail in the tables).
The tabular summary provides insight into additional experi-
ments that may be required, for example there is a gap in this col-
lection with respect to measuring diabetes directly for several of
the pharmacological treatments. These endpoints were identiﬁed
in the small set of 9200 articles but the automated methods pre-
sented in this paper scale naturally to larger collections of
full-text articles to provide a more complete picture of endpoints
that hadbeen studied so that scientists andpolicymakers canobtain
a better picture of where results differ and where there are gaps.
In contrast to Table 10 that shows endpoints with different rep-
resentations, Table 11 shows endpoints that occurred only once in
the human studies. Much of the intellectual work in a systematic
review involves reconciling information that may seemcompare with Metformin in human studies. Numbers reﬂect pubmed identiﬁers and *
Lifestyle intervention Placebo
yclosporin A
sA)
Intensive lifestyle
intervention
Moderate-intensity
treadmill running
Placebo/control
Similar
activation 12086935
M < placebo
15855347 M < ⁄
placebo 15855347
imilar to M
nhibition) 15983220
L < M 15855347
No ⁄
differences 15855325
L < M 15855347
No
difference 12765948
No changes by
M 12540598
Table 12
Tabular summary of endpoints used to measure howwell interventions compare with Metformin in animal studies. Numbers reﬂect pubmed idenﬁers and * means that the article
stated that the difference was signiﬁcant.
Endpoint S 422 Benﬂuorex Rosiglitazone Pioglitazone Control 5-aminoimida-zole-4-
carbo-xamide riboside
AMPKK1/AMPKK2
Expression of glycolytic and
gluconeogenic enzymes
S similar
M 12145146
B similar
M 12145146
Hepatic gluconeogenesis
(mechanisms for
reduction)
B markedly
different to
M 12145146
AMP-activated protein
kinase (AMPK)
A different to M 12145153
Metabolic effects A very similar to
M 12145153
Complex I inhibition R inhibited (M
did not) 15047621
P inhibited (M
did not) 15047621
Respiratory control R < M ;15047621 P < M ; 15047621
ADP-to-oxygen ratios with
succinate
R < M ; 15047621 P < M ; 15047621
Upstream kinase M might act differently
AMPKK1/AMPKK 12145153
Peak fractional cell
shortening (PS)
C unaffected by
M 11334425
Islet amyloid prevalence (and
severity)
R reduced⁄
M 15983227
Proportion of beta-cell mass
to islet mass
M > ⁄ C 15983227
Beta-cell mass M < C 15983227
Mean islet mass C not different to
M 15983227
Islet mass C not different to
M 15983227
M < C 15983227
Human islet amyloid poly-
peptide (hIAPP) contents
C not different to M
(P = 0.2) 15983227
Mouse islet amyloid
polypeptide contents
C not different to M
(P = 0.07) 15983227
Pancreatic insulin content M < C
(P < 0.05) 15983227
Fasting plasma hIAPP M < C
(P < 0.01) 15983227
Body weight M < C 15983227
Fat mass M < ⁄ C 15983227
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Metformin is both similar to and different from Troglitazone with
respect to the endpoint Akt activity. In this case the user could
return to the original sentences (shown below as 16 and 17) and
would see that these ﬁndings are consistent with the experimental
results reported in the article.
(16) The small effect of insulin to stimulate Akt activity[end-
point] before metformin treatment[agent] was similar to that in
the troglitazone group[object] before treatment (NS).
(17) However, in contrast to troglitazone treatment[agent],
there was no enhancement of Akt activation[endpoint] in response
to insulin after metformin treatment[object] (Fig. 2B).
Endpoints used in the ﬁve articles containing veriﬁed compar-
isons and involving studies with animals (i.e. the article had
been assigned a MeSH of Animal) are shown in Table 12. The
endpoints used in these experiments (see the ﬁrst column) tend
to focus on molecular and cellular activities that provide insight
into the underlying mechanisms rather than the higher level
endpoints measured in human studies. One of the advantages
of using the system described in this paper is that a user
does not need to fully articulate the endpoints shown in Tables
10–12 in advance, but rather the endpoints are identiﬁed auto-
matically by the system.5. Conclusions
Writing a systematic review currently requires thousands of
hours of manually sifting through peer-reviewed literature, but
the subsequent summary that reconciles results from multiple
studies is the bedrock of evidence-based medicine. We introduce
a two-step approach to automatically extract three facets from
direct comparative sentences: two entities that participate in the
comparison (the agent and object), and the way in which the enti-
ties are compared (the endpoint). The approach leverages sentence
structure and removes the need for a user to specify which entities
should be extracted ahead of time. This enables the system to be
used in domains where entity recognition is difﬁcult or where
existing ontologies are not available.
Experiments were conducted using a collection of more than
2 million sentences. The F1 and accuracy measures for the support
vector machine and the general linear models differed by only 0.01
across all three facts extracted in a test set. Objects were the easi-
est to identify with maximum accuracy of 92%, whereas the agent
and endpoints resulted in an accuracy of 73%. F1 scores in the over-
all test set were higher for objects (maximum 0.77) than endpoints
(0.51) and agents (maximum 0.47).
The situated evaluation based on a frequently occurring concept
(Metformin) using three tabular summaries of the extracted noun
phrases from the 56 veriﬁed sentences was presented that showed
how studies agree and disagree, and how the output of this system
56 C. Blake, A. Lucic / Journal of Biomedical Informatics 56 (2015) 42–56can show gaps in the literature. As with a systematic review, the
tabular summary includes links back to the original article to
ensure that the noun phrases are uniﬁed in a way that accurately
reﬂects the intent from the original article. Both the system accu-
racy (95%, 83% and 79% for the object, endpoint and agent respec-
tively) and the F1 scores (0.89, 0.64, and 0.62 for the object,
endpoint and agent respectively) were higher in the situated eval-
uation, which suggests that it may be easier to detect agent, object,
and endpoint roles in direct comparison sentences that include a
drug name.
Although only a small proportion (5.31%) of the more than
2 million sentences in the 9200 full-text articles in this study are
direct comparisons, the situated evaluation showed that in addi-
tion to measuring diabetes directly, scientists also measure insulin
and glucose endpoints when evaluating a new intervention. In
addition to supporting a systematic review, the tabular summaries
can also be used by policy makers to identify areas where there are
experimental gaps, for example, several of the pharmacological
treatments in this collection did not measure diabetes directly.
Although these results have yet to be combined with other types
of claims (speciﬁcally the explicit claims) the tabular summaries
suggest that direct comparison sentences provide a rich source of
currently underutilized information that can be used to accelerate
the systematic review process and show where future research
should be focused.Conﬂict of interest
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